Efficacy of '8-drugs-in-one-day' combination in treatment of recurrent GBM patients

A. Boiardi, A. Silvani, I. Milanesi, G. Broggi, L. Fariselli

Research output: Contribution to journalArticle

Abstract

Thirty-five adult recurrent GBM patients, divided randomly in two groups of 19 and 16 cases, had been treated with two regimens of chemotherapy: a) 'eight-drugs-in-one-day'; b) procarbazine + CCNU + vincristine (PCV) respectively. Chemotherapy was planned at the tumor relapse and delivered as long as tolerated without irreversible sequelae or until the CT scan showed tumor progression. Multiple agents are used simultaneously in the therapeutic approach using 'eight-in-one' to kill as many heterogeneous cells of malignant glial tumor as possible and minimize the emergence of cellular resistance to chemotherapy. Rate response to chemotherapy and the median adjunctive survival time (6.5 and 6 months, respectively) are not significantly different in the two arms of this study. Our experience with such an aggressive multi-drugs combination 'eight-in-one-day' was disappointing if compared with less toxic, better tolerated and easy delivered (PCV) regimen.

Original languageEnglish
Pages (from-to)153-158
Number of pages6
JournalJournal of Neuro-Oncology
Volume12
Issue number2
DOIs
Publication statusPublished - Feb 1992

Fingerprint

Lomustine
Procarbazine
Drug Therapy
Vincristine
Pharmaceutical Preparations
Poisons
Drug Combinations
Therapeutics
Glioma
Neoplasms
Recurrence
Survival

Keywords

  • 'eight-in-one day'
  • chemotherapy
  • recurrent glioma

ASJC Scopus subject areas

  • Neuroscience(all)
  • Oncology
  • Clinical Neurology
  • Cancer Research

Cite this

Efficacy of '8-drugs-in-one-day' combination in treatment of recurrent GBM patients. / Boiardi, A.; Silvani, A.; Milanesi, I.; Broggi, G.; Fariselli, L.

In: Journal of Neuro-Oncology, Vol. 12, No. 2, 02.1992, p. 153-158.

Research output: Contribution to journalArticle

@article{f1d3de3cd1e9495e86f23f2f51b46b6b,
title = "Efficacy of '8-drugs-in-one-day' combination in treatment of recurrent GBM patients",
abstract = "Thirty-five adult recurrent GBM patients, divided randomly in two groups of 19 and 16 cases, had been treated with two regimens of chemotherapy: a) 'eight-drugs-in-one-day'; b) procarbazine + CCNU + vincristine (PCV) respectively. Chemotherapy was planned at the tumor relapse and delivered as long as tolerated without irreversible sequelae or until the CT scan showed tumor progression. Multiple agents are used simultaneously in the therapeutic approach using 'eight-in-one' to kill as many heterogeneous cells of malignant glial tumor as possible and minimize the emergence of cellular resistance to chemotherapy. Rate response to chemotherapy and the median adjunctive survival time (6.5 and 6 months, respectively) are not significantly different in the two arms of this study. Our experience with such an aggressive multi-drugs combination 'eight-in-one-day' was disappointing if compared with less toxic, better tolerated and easy delivered (PCV) regimen.",
keywords = "'eight-in-one day', chemotherapy, recurrent glioma",
author = "A. Boiardi and A. Silvani and I. Milanesi and G. Broggi and L. Fariselli",
year = "1992",
month = "2",
doi = "10.1007/BF00172666",
language = "English",
volume = "12",
pages = "153--158",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Springer New York LLC",
number = "2",

}

TY - JOUR

T1 - Efficacy of '8-drugs-in-one-day' combination in treatment of recurrent GBM patients

AU - Boiardi, A.

AU - Silvani, A.

AU - Milanesi, I.

AU - Broggi, G.

AU - Fariselli, L.

PY - 1992/2

Y1 - 1992/2

N2 - Thirty-five adult recurrent GBM patients, divided randomly in two groups of 19 and 16 cases, had been treated with two regimens of chemotherapy: a) 'eight-drugs-in-one-day'; b) procarbazine + CCNU + vincristine (PCV) respectively. Chemotherapy was planned at the tumor relapse and delivered as long as tolerated without irreversible sequelae or until the CT scan showed tumor progression. Multiple agents are used simultaneously in the therapeutic approach using 'eight-in-one' to kill as many heterogeneous cells of malignant glial tumor as possible and minimize the emergence of cellular resistance to chemotherapy. Rate response to chemotherapy and the median adjunctive survival time (6.5 and 6 months, respectively) are not significantly different in the two arms of this study. Our experience with such an aggressive multi-drugs combination 'eight-in-one-day' was disappointing if compared with less toxic, better tolerated and easy delivered (PCV) regimen.

AB - Thirty-five adult recurrent GBM patients, divided randomly in two groups of 19 and 16 cases, had been treated with two regimens of chemotherapy: a) 'eight-drugs-in-one-day'; b) procarbazine + CCNU + vincristine (PCV) respectively. Chemotherapy was planned at the tumor relapse and delivered as long as tolerated without irreversible sequelae or until the CT scan showed tumor progression. Multiple agents are used simultaneously in the therapeutic approach using 'eight-in-one' to kill as many heterogeneous cells of malignant glial tumor as possible and minimize the emergence of cellular resistance to chemotherapy. Rate response to chemotherapy and the median adjunctive survival time (6.5 and 6 months, respectively) are not significantly different in the two arms of this study. Our experience with such an aggressive multi-drugs combination 'eight-in-one-day' was disappointing if compared with less toxic, better tolerated and easy delivered (PCV) regimen.

KW - 'eight-in-one day'

KW - chemotherapy

KW - recurrent glioma

UR - http://www.scopus.com/inward/record.url?scp=0026536938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026536938&partnerID=8YFLogxK

U2 - 10.1007/BF00172666

DO - 10.1007/BF00172666

M3 - Article

C2 - 1313860

AN - SCOPUS:0026536938

VL - 12

SP - 153

EP - 158

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 2

ER -